​

Kura Oncology (KURA) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

KURA Stock Forecast

Kura Oncology (KURA) stock forecast, based on 13 Wall Street analysts, predicts a 12-month average price target of $12.50, with a high of $14.00 and a low of $11.00. This represents a 117.39% increase from the last price of $5.75.

$5 $9 $13 $17 $21 $25 High: $14 Avg: $12.5 Low: $11 Last Closed Price: $5.75

KURA Stock Rating

Kura Oncology stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (84.62%), 2 Hold (15.38%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 13 0 2 11 Strong Sell Sell Hold Buy Strong Buy

KURA Price Target Upside V Benchmarks

TypeNameUpside
StockKura Oncology117.39%
SectorHealthcare Stocks 33.91%
IndustryBiotech Stocks 83.49%

Price Target Trends

1M3M12M
# Anlaysts-16
Avg Price Target-$14.00$21.83
Last Closing Price$5.75$5.75$5.75
Upside/Downside-143.48%279.65%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 253103--16
Mar, 253103--16
Feb, 253112--16
Jan, 253112--16
Dec, 243112--16
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 06, 2025UBS$14.00$7.7081.82%143.48%
Nov 22, 2024Bradley CaninoStifel Nicolaus$11.00$10.801.85%91.30%
Oct 24, 2024David DaiUBS$27.00$17.0258.64%369.57%
Oct 14, 2024Bradley CaninoStifel Nicolaus$19.00$18.582.26%230.43%
Jun 25, 2024Joseph PantginisH.C. Wainwright$32.00$21.0851.80%456.52%
May 23, 2024Bradley CaninoStifel Nicolaus$28.00$21.4330.66%386.96%
Dec 22, 2023Mara GoldsteinMizuho Securities$26.00$13.8188.27%352.17%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 18, 2024H.C. WainwrightBuyBuyhold
Oct 24, 2024UBSBuyinitialise
Jun 25, 2024H.C. WainwrightBuyBuyhold
Feb 25, 2022Credit SuisseOutperformOutperformhold
Feb 25, 2022SVB LeerinkOutperformOutperformhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 $2 $3 $4 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.08$-2.02----
Avg Forecast$-2.08$-2.39$-1.96$-1.86$-1.30$-0.30
High Forecast$-2.01$-2.14$0.71$0.97$3.14$0.08
Low Forecast$-2.20$-2.50$-3.24$-3.70$-3.91$-0.86
Surprise %--15.48%----

Revenue Forecast

$0 $300M $600M $900M $1B $2B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$53.88M----
Avg Forecast-$7.19M$67.41M$145.46M$273.85M$488.33M
High Forecast-$12.51M$163.54M$147.09M$281.32M$1.18B
Low Forecast-$1.04M$1.48M$143.82M$266.37M$10.75M
Surprise %-649.18%----

Net Income Forecast

$-300M $-190M $-80M $30M $140M $250M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-152.63M$-173.98M----
Avg Forecast$-152.63M$-170.01M$-176.77M$-166.69M$-124.39M$-22.01M
High Forecast$-147.21M$-156.76M$52.31M$71.08M$230.23M$5.97M
Low Forecast$-161.06M$-183.25M$-237.62M$-270.84M$-286.33M$-62.80M
Surprise %-2.34%----

KURA Forecast FAQ

Is Kura Oncology stock a buy?

Kura Oncology stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Kura Oncology is a favorable investment for most analysts.

What is Kura Oncology's price target?

Kura Oncology's price target, set by 13 Wall Street analysts, averages $12.5 over the next 12 months. The price target range spans from $11 at the low end to $14 at the high end, suggesting a potential 117.39% change from the previous closing price of $5.75.

How does Kura Oncology stock forecast compare to its benchmarks?

Kura Oncology's stock forecast shows a 117.39% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the biotech stocks industry (83.49%).

What is the breakdown of analyst ratings for Kura Oncology over the past three months?

  • April 2025: 18.75% Strong Buy, 62.50% Buy, 18.75% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 18.75% Strong Buy, 62.50% Buy, 18.75% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 18.75% Strong Buy, 68.75% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.

What is Kura Oncology’s EPS forecast?

Kura Oncology's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.96, marking a -2.97% decrease from the reported $-2.02 in 2024. Estimates for the following years are $-1.86 in 2026, $-1.3 in 2027, and $-0.3 in 2028.

What is Kura Oncology’s revenue forecast?

Kura Oncology's average annual revenue forecast for its fiscal year ending in December 2025 is $67.41M, reflecting a 25.11% increase from the reported $53.88M in 2024. The forecast for 2026 is $145.46M, followed by $273.85M for 2027, and $488.33M for 2028.

What is Kura Oncology’s net income forecast?

Kura Oncology's net income forecast for the fiscal year ending in December 2025 stands at $-177M, representing an 1.60% increase from the reported $-174M in 2024. Projections indicate $-167M in 2026, $-124M in 2027, and $-22.006M in 2028.